DMG: New: from Alpecin research
Clinical efficacy study with innovative DMG and caffeine-containing shampoo shows tremendous effectiveness against hereditary hair loss
Until now, both the topical application and the effect of DMG on skin and hair cells were completely unexplored. Current studies from a European research network now show that the microcirculation of the skin, meaning the blood flow in the smallest blood vessels, is increased with the topical application of DMG and additionally provide insights into the mechanism of action of DMG in the cells.
What distinguishes Alpecin research?
At the heart of Alpecin research efforts is the scientifically proven benefit of our products. Since the company's founding, we have maintained close collaboration with renowned scientists. This forms the basis for our research into novel active ingredients and our innovative product developments.
Dr. Erik Schulze zur Wiesche
Head of Research & Development
Double-blind, randomised, and placebo-controlled study on 154 men with hereditary hair loss. Conducted at the Centre for Cosmetic Research, Catholic University of the Sacred Heart in Rome, Italy.
Discover which Alpecin product suits you best - tailored individually for strong hair and a healthy scalp.
Conducted at the Clinic for Dermatology and Dermatological Allergology at Friedrich Schiller University Jena.
Conducted at five different research institutes in Germany, Austria, the USA and the UK
Conducted at the Clinic and Polyclinic for Dermatology and Venereology at the University of Hamburg-Eppendorf
Carried out at the Monasterium Laboratory Skin & Hair research Solutions GmbH, Münster
Conducted at the Center for Experimental and Applied Skin Physiology and Clinical Research Center for Hair and Skin Physiology of the Charité University Hospital, Berlin
Conducted at the Center for Cosmetic Research at Sacred Heart Catholic University in Rome, Italy.
Conducted at the Center for Cosmetic Research at Sacred Heart Catholic University in Rome, Italy.
Conducted by Derma Consult GmbH company for the testing of dermatics
Double-blind, randomized, and placebo-controlled study on 154 men with hereditary hair loss. Conducted at the Center for Cosmetic Research, Catholic University of the Sacred Heart in Rome, Italy.
Conducted at five research centers under the direction of Lokmanya Tilak Municipal General Hospital in Mumbai (India)
Conducted by the dermatological group practice Dr. Peter, Dr. Seeber, Hamburg
Conducted at the Center for Cosmetic Research at Sacred Heart Catholic University in Rome
The focus of Alpecin research is the scientifically proven benefit of our products.
